Abbott Laboratories ABT1.77%increase; green up pointing triangle agreed to acquire cancer diagnostics company Exact Sciences EXAS 0.14%increase; green up pointing triangle in a deal valued at about ...

Abbott Laboratories could be looking to acquire Exact Sciences, according to a report from Bloomberg, citing people close to the deal. News of the rumored deal caused Madison, WI-based Exact Sciences ...

After cleaning house and seeing six coaches exit following the Mets' collapse at the end of the 2025 season, the club has officially announced the overhaul of its coaching staff on Wednesday afternoon ...

Abbott to buy Exact Sciences in $23 billion deal Exact's flagship colorectal cancer test to join Abbott's portfolio Abbott eyes international expansion for Exact's tests Aims for broad reimbursement ...

Bro almost touches 100 across the diamond and now this? He’s gonna be insane once he gets accustomed to Big League pitching #MLB #baseball #mlbtiktok #baseballtiktok #baseballtiktoks #baseballboys ...

Texas Gov. Greg Abbott (R) vowed Tuesday that he would appeal a ruling that a new GOP-favored map that Republicans passed earlier this year could not be used for the 2026 midterms. “The Legislature ...

Abbott announced on Thursday, Nov. 20 it plans to buy Exact Sciences, a Madison-based maker of cancer screening and diagnostic tests, in a deal valued at an estimated $23 billion, including debt. The ...

North suburban-based Abbott Laboratories announced a $21 billion deal Thursday morning to acquire Exact Sciences, the maker of Cologuard — its largest acquisition in a decade. The deal will allow ...

Abbott Laboratories is nearing a potential acquisition of cancer screening company Exact Sciences Corp., people familiar with the matter said, in what could be the biggest deal of the year in the ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. Abbott said Thursday it would buy Exact Sciences, the maker of tests ...

Forbes contributors publish independent expert analyses and insights. Bruce Japsen writes about healthcare business and policy. Abbott Laboratories $21 billion deal to acquire cancer test maker Exact ...

In January, Exact Sciences CEO Kevin Conroy told us that 2025 was shaping up to be a transformative year for the diagnostics company. Three cancer test launches, multiple study readouts and one $23 ...